Bei Chen Selected Research

Nasal Polyps (Nasal Polyp)

1/2018	Solitary chemosensory cells are a primary epithelial source of IL-25 in patients with chronic rhinosinusitis with nasal polyps.
1/2017	Denatonium-induced sinonasal bacterial killing may play a role in chronic rhinosinusitis outcomes.
11/2011	Superantigen-induced glucocorticoid insensitivity in the recurrence of chronic rhinosinusitis with nasal polyps.
8/2008	Superantigens and the expression of T-cell receptor repertoire in chronic rhinosinusitis with nasal polyps.
1/2008	The role of superantigens in chronic rhinosinusitis with nasal polyps.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bei Chen Research Topics

Disease

28	Neoplasms (Cancer) 01/2024 - 11/2003
12	Rhinosinusitis 01/2017 - 05/2007
10	Stomach Neoplasms (Stomach Cancer) 01/2023 - 04/2008
9	Inflammation (Inflammations) 12/2023 - 05/2006
7	Infections 01/2023 - 05/2006
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 03/2013
5	Echinococcosis (Hydatid Cysts) 12/2023 - 01/2020
5	Nasal Polyps (Nasal Polyp) 01/2018 - 01/2008
4	Bacterial Infections (Bacterial Infection) 02/2021 - 03/2014
4	Neoplasm Metastasis (Metastasis) 01/2014 - 02/2009
3	Lung Neoplasms (Lung Cancer) 03/2023 - 03/2013
3	Wounds and Injuries (Trauma) 01/2023 - 07/2013
3	Diabetic Nephropathies (Diabetic Nephropathy) 09/2022 - 01/2022
3	Circulating Neoplastic Cells 03/2022 - 04/2019
3	Pneumonia (Pneumonitis) 06/2021 - 07/2002
3	Human Influenza (Influenza) 06/2021 - 09/2011
3	Septic Shock (Toxic Shock Syndrome) 11/2011 - 01/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 07/2013
2	Fatigue 01/2024 - 07/2022
2	Stroke (Strokes) 01/2024 - 01/2023
2	Hypertension (High Blood Pressure) 12/2023 - 01/2022
2	Osteoporosis 10/2023 - 01/2021
2	Hypoxia (Hypoxemia) 01/2023 - 01/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 09/2022 - 01/2020
2	COVID-19 07/2022 - 03/2022
2	Hyperglycemia 01/2022 - 03/2014
2	Viral Pneumonia 06/2021 - 02/2021
2	Virus Diseases (Viral Diseases) 06/2021 - 09/2011
2	Hearing Loss (Hearing Impairment) 01/2021 - 01/2020
2	Cysts 06/2020 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2019 - 03/2017
2	Polyps 01/2018 - 01/2008
2	Pain (Aches) 01/2018 - 01/2017
2	Postoperative Pain 01/2018 - 01/2016
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2017 - 01/2017
2	Esophageal Squamous Cell Carcinoma 11/2014 - 01/2014
2	Respiratory Tract Diseases (Respiratory Tract Disease) 05/2014 - 03/2014
2	Allergic Rhinitis 03/2014 - 12/2013
2	Adenocarcinoma of Lung 01/2014 - 03/2013
2	Presbycusis 08/2011 - 07/2010
2	Squamous Cell Carcinoma of Head and Neck 03/2004 - 11/2003
1	Nasopharyngeal Carcinoma 05/2024
1	Sepsis (Septicemia) 03/2024
1	Male Infertility (Male Sterility) 03/2024
1	Metabolic Diseases (Metabolic Disease) 01/2024

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2024 - 11/2003
6	DNA (Deoxyribonucleic Acid)IBA 05/2022 - 03/2004
5	Peptides (Polypeptides)IBA 01/2024 - 10/2008
4	Glucose (Dextrose)FDA LinkGeneric 05/2023 - 03/2014
4	EnzymesIBA 11/2011 - 01/2008
4	ImmunosorbentsIBA 11/2011 - 01/2008
3	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2012
3	Harmine (Telepathine)IBA 12/2023 - 06/2020
3	Therapeutic UsesIBA 01/2023 - 09/2009
3	Circular RNAIBA 12/2022 - 10/2017
3	CytokinesIBA 05/2022 - 06/2014
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 10/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2021 - 11/2009
3	Messenger RNA (mRNA)IBA 07/2020 - 03/2013
3	SuperantigensIBA 11/2011 - 01/2008
3	ExotoxinsIBA 11/2011 - 01/2008
2	TeaIBA 03/2024 - 01/2023
2	Insulin (Novolin)FDA Link 01/2024 - 01/2022
2	Caspase 3 (Caspase-3)IBA 01/2023 - 02/2009
2	SmokeIBA 12/2022 - 11/2009
2	HydrogelsIBA 03/2022 - 04/2021
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2022 - 01/2018
2	Photosensitizing Agents (Photosensitizers)IBA 01/2022 - 03/2013
2	Phospholipases (Phospholipase)IBA 06/2021 - 02/2021
2	Albendazole (Albenza)FDA Link 06/2020 - 03/2020
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 08/2012
2	Folic Acid (Vitamin M)FDA LinkGeneric 07/2019 - 03/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 06/2014
2	Interleukin-15 (Interleukin 15)IBA 03/2017 - 06/2014
2	FlavonesIBA 01/2017 - 01/2017
2	LipopolysaccharidesIBA 12/2016 - 07/2002
2	LigandsIBA 02/2016 - 06/2014
2	Antimicrobial PeptidesIBA 01/2016 - 03/2014
2	Tyrosine Kinase InhibitorsIBA 12/2015 - 01/2014
2	ErbB Receptors (EGF Receptor)IBA 12/2015 - 01/2014
2	Activating Transcription Factor 4IBA 11/2014 - 01/2014
2	Gefitinib (Iressa)FDA Link 01/2014 - 08/2013
2	Galactose (Galactopyranose)FDA LinkGeneric 08/2011 - 07/2010
2	Small Interfering RNA (siRNA)IBA 06/2010 - 06/2009
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 03/2024
1	2'- (2- hydroxyphenyl)- 2'- thiazoline- 4'- carboxylic acidIBA 03/2024
1	IntegrinsIBA 01/2024
1	NEDD8 ProteinIBA 01/2024
1	Protamines (Protamine Sulfate)FDA Link 01/2024

Therapy/Procedure

18	Therapeutics 12/2023 - 10/2008
6	Drug Therapy (Chemotherapy) 12/2023 - 04/2008
5	Acupuncture Points (Acupuncture Point) 09/2022 - 01/2022
4	Electroacupuncture 09/2022 - 01/2018
3	Radiotherapy 03/2023 - 03/2004
3	Aftercare (After-Treatment) 11/2022 - 01/2018
3	Immunotherapy 01/2022 - 03/2017
2	Injections 01/2024 - 04/2021
2	Percutaneous Collagen Induction 07/2022 - 01/2018
2	Oral Administration 06/2021 - 01/2020
1	Induction Chemotherapy 05/2024